HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Piers Blombery Selected Research

Stomatitis

8/2014The choice of multiple myeloma induction therapy affects the frequency and severity of oral mucositis after melphalan-based autologous stem cell transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Piers Blombery Research Topics

Disease

17Neoplasms (Cancer)
01/2023 - 10/2011
10B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
08/2023 - 01/2019
6Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
11/2023 - 01/2019
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2023 - 01/2018
4Myelodysplastic Syndromes (Myelodysplastic Syndrome)
03/2024 - 05/2016
4Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2023 - 04/2021
3Lymphoma (Lymphomas)
01/2023 - 01/2018
3Multiple Myeloma
06/2022 - 10/2011
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2021 - 02/2011
3Disease Progression
01/2020 - 01/2019
3Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2019 - 01/2016
3Thrombotic Thrombocytopenic Purpura
06/2018 - 01/2014
3Infections
06/2018 - 10/2011
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2023 - 01/2019
2VEXAS syndrome
01/2023 - 11/2022
2Residual Neoplasm
01/2022 - 01/2020
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 01/2020
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 10/2021
2T-Cell Lymphoma (Lymphoma, T Cell)
11/2018 - 11/2009
2Malignant Hypertension
06/2018 - 01/2018
2Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2017 - 11/2009
1Aplastic Anemia (Anemia, Hypoplastic)
01/2024
1Erdheim-Chester Disease
01/2023
1Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell)
01/2023
1Inflammation (Inflammations)
01/2023
1Cytopenia
01/2023
1Autosomal Recessive 3 Severe Congenital Neutropenia
01/2023
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2022
1Hematologic Neoplasms (Hematological Malignancy)
06/2022
1Bone Marrow Failure Disorders
01/2022
1Cytomegalovirus Infections (Inclusion Disease)
10/2021
1Acquired Immunodeficiency Syndrome (AIDS)
04/2021
1Glomerulonephritis
01/2021
1Paraproteinemias (Monoclonal Gammopathy)
01/2021
1Chromosome Fragility
06/2020
1Prostatic Neoplasms (Prostate Cancer)
01/2020
1Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
01/2019
1Leukemia
01/2018
1Stomatitis
08/2014
1Neutropenia
08/2014
1Mucositis
08/2014

Drug/Important Bio-Agent (IBA)

14venetoclaxIBA
01/2023 - 01/2019
4Rituximab (Mabthera)FDA Link
11/2023 - 02/2011
4ibrutinibIBA
10/2023 - 01/2019
4Agammaglobulinaemia Tyrosine KinaseIBA
02/2023 - 10/2021
4DNA (Deoxyribonucleic Acid)IBA
01/2023 - 01/2021
3Chimeric Antigen ReceptorsIBA
10/2023 - 04/2021
3thiamine triphosphorate (TTP)IBA
06/2018 - 01/2014
2LigandsIBA
01/2023 - 01/2018
2Immune Checkpoint InhibitorsIBA
01/2023 - 10/2021
2Immunoglobulins (Immunoglobulin)IBA
01/2023 - 01/2021
2Azacitidine (5 Azacytidine)FDA Link
01/2023 - 01/2019
2Proteins (Proteins, Gene)FDA Link
11/2022 - 01/2022
2RNA (Ribonucleic Acid)IBA
01/2022 - 01/2022
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
10/2021 - 11/2018
2Circulating Tumor DNAIBA
01/2019 - 01/2017
2Shiga Toxin (Shigella Toxin)IBA
06/2018 - 01/2018
2romidepsin (FK228)FDA Link
01/2017 - 11/2009
1OMS 2017IBA
03/2024
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2024
1avatrombopagIBA
01/2024
1Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
01/2024
1Cytarabine (Cytosar-U)FDA LinkGeneric
11/2023
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2023
1ProteomeIBA
01/2023
1VemurafenibIBA
01/2023
1Phosphotransferases (Kinase)IBA
01/2023
1dabrafenibIBA
01/2023
1Initiator Codon (Start Codon)IBA
01/2023
1avelumabIBA
01/2023
1EnzymesIBA
11/2022
1Biomarkers (Surrogate Marker)IBA
06/2022
1Telomerase (Telomerase Reverse Transcriptase)IBA
01/2022
1tert-butylserineIBA
01/2022
1DNA Glycosylases (DNA Glycosylase)IBA
01/2022
1CD19-specific chimeric antigen receptorIBA
10/2021
1ParaffinIBA
10/2021
1Formaldehyde (Formol)FDA Link
10/2021
1Complement System Proteins (Complement)IBA
06/2020
1Radioisotopes (Radionuclides)IBA
08/2019
1Peptide Receptors (Peptide Receptor)IBA
08/2019
1Antineoplastic Agents (Antineoplastics)IBA
01/2019
1CX 5461IBA
01/2019
1Ribosomal DNA (rDNA)IBA
01/2019
1Lenalidomide (CC 5013)FDA Link
01/2019
1RNA Polymerase I (Polymerase I, RNA)IBA
01/2019
1CopperIBA
05/2016
1Melphalan (Alkeran)FDA LinkGeneric
08/2014

Therapy/Procedure

16Therapeutics
01/2023 - 08/2014
7Drug Therapy (Chemotherapy)
02/2023 - 08/2014
3Stem Cell Transplantation
11/2023 - 10/2011
3Breast Implants (Breast Implant)
01/2019 - 01/2016
1Autologous Transplantation
11/2023
1Remission Induction
01/2022
1Immunotherapy
04/2021
1Brachytherapy
01/2020
1Prostheses and Implants (Prosthesis)
11/2018
1Induction Chemotherapy
01/2018
1Analgesia
08/2014
1Total Parenteral Nutrition
08/2014